Improve patient outcomes, avoid needless isolation costs, and act fast to prevent outbreak situations with xTAG ® GPP.
From a single and simple laboratory test, you can get results for 14 of the most common causes of infectious gastroenteritis from a single stool sample in less than 5 hours. xTAG GPP is a qualitative multiplex test intended for the simultaneous detection and identification of nucleic acids from multiple gastroenteritis-causing viruses, bacteria and parasites (including toxin gene detection) in human stool samples.
This panelwill replace traditional stool culture (STOCU) and the Giardia and Cryptosporidium antigen(OVPSC) screen.
New Account Request (800) 295-0529
Methodology: | Polymerase chain reaction (PCR) |
Performed: | Mon-Fri |
Reported: | 1-3 days |
Specimen Required: | Collect :Small amount of fecal material - 2 g. or 2 mL liquid stool.
Specimen preparation:Place into screw top Sterile Container.Storage/Transport Temperature:Refrigerated Stability:Refrigerated : 48 hours, Frozen : 48 hours NOTE:* This test is not available for New York patients, please refer to test codeN630for specimen requirements.*Performing Laboratory Accu Reference Medical Laboratory |
CPT Code(s): | 87507 |
Test Panel Components | Detects gastrointestinal pathogen targets: Adenovirus (40/41), Campylobacter , Clostridium difficile toxin A/B, Cryptosporidium , Entamoeba histolytica, Escherichia coli O157, Enterotoxigenic Escherichia coli (ETEC) LT/ST, Giardia (G. lamblia), Norovirus GI/GII, Rotavirus A, Salmonella, Shiga Toxin-producing Escherichia coli (STEC) stx1/stx2, Shigella , Vibrio cholera. |
PDF Document | GPP Brochure.pdf |
Sample Report | |
Additional Information |
|
The benefits ofGPP
1 Stool Sample, 1 Test, 14 ResultsâMore results faster, enabling a higher diagnostic yield.
xTAG GPP offers the ability to non-invasively analyze patient stool samples for 14 GI pathogen targets simultaneously and at a much quicker processing time, as compared with conventional industry testing methods.
- Superior sensitivity and specificity for detection of the most common enteric pathogens.
- Faster diagnosis of gastrointestinal infections with fewer tests and reduced costs.
- Co-infections determined by one multi-pathogen panel versus multiple tests.
Testing should be performed on individuals exhibiting signs and symptoms of gastrointestinal infection and to aid in the diagnosis of gastrointestinal infection when used in conjunction with clinical evaluation, laboratory findings, and epidemiological information. A gastrointestinal microorganism multiplex nucleic acid-based assay also aids in the detection and identification of acute gastroenteritis in the context of outbreaks (1).
This test is not recommended for in-patients hospitalized for more than 3 days.
Procedure
The target is amplified using polymerase chain reaction (PCR) or reverse transcription PCR, then analyzed with Luminex xTAG technology to detect the presence or absence of each pathogen in the panel. The test has been cleared or approved for diagnostic use by the U.S. Food and Drug Administration for fecal specimens.
Disclaimer
Information derived from Gastrointestinal Pathogen Panel Package Insert (Luminex Corporation). Gastrointestinal Pathogen Panel is a product of Luminex Corporation. xTAG is a registered trademark of Luminex Corporation. Luminex is a registered trademark of Luminex Corporation.
Test Overview
When should the testing be ordered?
In healthcare settings and in specific populations (newborns/infants, elderly or immunocompromised patients), these infections are potentially serious. Rapid diagnosis is important for appropriate treatment and infection control measures.
References
Physician Lab Services: New Account Request (800) 295-0529